ABSTRACT Bacteria have a natural propensity to grow as sessile, matrix-encapsulated, multicellular communities called biofilms.
In a review published in 1896 on early bacteriological studies of the tubercle bacilli, Mycobacterium tuberculosis, A. Coppen Jones (1) wrote:
When old cultures are examined by means of sections it is found that the growth does not consist of separated rod-like forms, isolated from one another and lying at angles, but of strands of parallel filaments, frequently showing dichotomous branching. These facts indicate that the so-called "tubercle bacillus" is really a stage in the life history of some higher form of fungus with definite mycellial growth. From a systemic point of view, it cannot be regarded as coming within any definition of the genus Bacillus, and it is suggested that a more appropriate name would be Tuberculomyces.
Despite an outrageous suggestion of calling M. tuberculosis a fungus, Jones's thought of "separated rod-like forms" and "strands of parallel filament" as alternative lifestyles of the tubercle bacilli is remarkably consistent with contemporary views of most bacteria: switching their lifestyle from single-cell planktonic forms to sessile, multicellular communities, called biofilms (2) (3) (4) . Moreover, biofilms are phenotypically unique from planktonic forms of their constituent cells in many ways, most notable of which is their extraordinary resistance to environmental challenges (5, 6) . Formation of biofilms therefore is considered a universal persistent strategy for microbes in diverse growth conditions.
The long-term persistence and extraordinary drug tolerance of mycobacterial infections, particularly M. tuberculosis, are strikingly similar to the characteristics of biofilm infections associated with many bacterial pathogens. Furthermore, many mycobacterial species, including M. tuberculosis, form drug-tolerant biofilms under in vitro conditions through genetically controlled developmental processes. Together, these raise pertinent questions as to whether mycobacterial infections could also be associated with a multicellular lifestyle of mycobacteria. In this article, while reviewing the characteristics of in vitro biofilms of mycobacteria we will discuss the relevance of biofilm models to developing an understanding of the persistence characteristics of mycobacterial infections.
ORIGINS OF THE BIOFILM HYPOTHESIS
Microbes were perhaps first described as communities of individual cells by Antonie van Leeuwenhoek in 1684 when he reported the microscopic observation of human dental "scuff" (plaques) as "animalcules." However, bacteriology, blooming under the influence of Koch's postulates, had a strong purpose of obtaining clonally pure strains from uniformly dispersed cultures. Thus, widespread culturing in nutrient-rich medium on shakers perhaps led to the common notion that bacteria predominantly grow in unicellular planktonic forms, although occasional studies in the early 20th century raised caution on this view. In an attempt to grow algae on a submerged glass surface, Henrici observed the surface to be fully colonized with bacteria (7). Subsequently, Heukelekian and Heller, as well as Claude Zobell, confirmed Henrici's observation (8, 9) . Planktonic cultures of bacteria, however, remained the mainstream culture technique, perhaps influenced by the urgencies of anti-infective discoveries. Not surprisingly, Tween-80 as a dispersing agent, first used by Dubos and colleagues (10) , continues to be a key medium ingredient for dispersed broth cultures of M. tuberculosis and other mycobacteria, despite a direct influence of the detergent on physical and biological characteristics of the pathogen (11, 12) .
Between the late 1970s and early 1980s Costerton and colleagues published a series of electron micrographs of a wide range of specimens, from rumen fluids to medical implants, showing bacterial populations as adherent microcolonies encapsulated by exopolysaccharide (EPS) (13) (14) (15) . It was further observed that these sessile communities are distinct in terms of their recalcitrance to antimicrobial agents (16) . These discoveries were followed by extensive microscopic observations of biotic and abiotic surfaces, and it subsequently became apparent that biofilms are the predominant lifestyle of microbes in both environmental and clinical settings and pose significant challenges in treatment of microbial infections.
BASIC CHARACTERISTICS OF MICROBIAL BIOFILMS Dynamic Architecture Encapsulated within Extracellular Matrix
Using confocal scanning laser microscopy (CSLM), Caldwell and colleagues showed that the biofilms of Pseudomonas fluorescence were not random aggregates, but were uniformly raised in mushroom-shaped structures (17) . Subsequently, Stoodley et al. demonstrated the presence of water channels in the interiors of Pseudomonas aeruginosa biofilms that were big enough to allow unrestricted flow of particles greater than 5 μm (18). These water channels are thought to deliver oxygen and nutrients to the microbial population residing in the inner structures of the biofilms (19) .
One of the invariable structural components of biofilm architecture is the extracellular matrix (ECM), which physically holds the individual cells together. Although the molecular composition of the ECM differs significantly across species, and even among strains within a species, EPS is one of the most predominant matrix components in both Gram-positive and Gramnegative species (20) . Extracellular DNA (eDNA) is also a structural component of the matrix in biofilms of P. aeruginosa and Staphylococcus aureus (21, 22) . In addition to EPS and eDNA, matrices of most species also contain adhesive proteins. For example, multiple biofilm-associated proteins (Bap) in S. aureus are sufficient to produce matured biofilms even without EPS (23) . Similarly, TasA in Bacillus subtilis (24) , type IV pili in P. aeruginosa (25) , and type I fimbria as well as curli in Escherichia coli (26, 27 ) are some of the major adhesive proteins implicated in cell-cell and cell-surface attachment.
Genetically Programmed Distinct Developmental Stages
Biofilm formation is a developmental process that proceeds through distinct stages of (i) surface attachment, (ii) sessile growth, (iii) matrix synthesis, and (iv) dispersal (Fig. 1) . Each stage appears to be associated with distinct sets of genetic factors, expressions of which are regulated through master regulators and signaling molecules. For example, mutation in Clp protease leads to defective attachment of P. aeruginosa to substratum (28) , suggesting that protein processing could be critical during attachment. Surface attachment of P. aeruginosa also induces expression of algC and, therefore, alginate synthesis (29) . In E. coli, surface attachment triggers activation of CsgD, followed by cyclic-di-GMP-dependent reprogramming of gene expression that suppresses motility while inducing sessile growth and matrix synthesis (30) . Many other Gram-negative species, as well as B. subtilis, also utilize cyclic-di-GMP as a secondary messenger during biofilm development (31) (32) (33) . Intercellular communication through a quorum-sensing phenomenon, involving autoinducers, is also widely implicated in biofilm formation of both Gram-negative and Gram-positive species (34-37). The intricacies of regulatory networks in biofilm development are further revealed by the implications of many transcriptional activators and suppressors in biofilm-specific traits, such as loss of motility and increased synthesis of EPS (30, (38) (39) (40) .
Phenotypic Heterogeneity
One of the most fascinating features of biofilms is that they harbor phenotypically heterogeneous cells even in a genetically clonal population (2) . Such phenotypic diversity presumably originates from cell-to-cell differences in gene expression, as a result of nonuniform microenvironments of the biofilms (41) (42) (43) . Promoter fusions with fluorescent reporters have been useful in the analysis of phenotypic heterogeneity in biofilms. By fusing green fluorescent protein to the growth-ratedependent promoter (rrnBP1) of P. aeruginosa, Stewart and colleagues demonstrated that the promoter activity and therefore growth was limited to the cells in the outer regions of biofilms (44) . Similarly, Vlamakis et al. observed distinct spatiotemporal organization of a motile, sessile, and sporulating subpopulation of bacilli within a colony-biofilm of B. subtilis (43) .
Genetically Controlled Dispersal
Both Gram-positive and Gram-negative species utilize genetically controlled mechanisms for programmed selfdispersal of biofilms. From an ecological perspective, dispersal can be thought to be an integral part of microbial dissemination (and recolonization) under immediate stress. Dispersal factors are of particular interest from clinical perspectives because these could lead to potential therapeutics for biofilm infections. In P. aeruginosa, dispersal is preceded by localized lysis of bacteria in the interior subpopulation, which then are believed to provide nutrients to immediate cells, which activate the expression of their motility genes to exit the community (45, 46) . Matured biofilms of B. subtilis secrete D-amino acids and norspermidine as dispersal factors, which interestingly, are also effective against other Gram-positive and Gram-negative species (47) (48) (49) . Potential of dispersal factors in the treatment of biofilm infections, however, remains to be evaluated.
BIOFILM AS A PERSISTENCE STRATEGY OF MICROBES
Formation of biofilms is arguably a significant commitment from microbes not only because a sessile form restricts their spatial freedom, but also because architectural development requires energy expenditure. In return, the encapsulated microbes in biofilms enjoy greater protection from various kinds of environmental threats such as antibiotics, protozoan predation, and host immunity (4, 5, (50) (51) (52) (53) . For many bacterial pathogens, biofilms are implicated in their survival against both host defense mechanisms and antibiotics (13, (54) (55) (56) (57) .
Recalcitrance to stress is likely a combined effect of both physical protection by ECM and physiological adaptation to limiting growth conditions of inner microenvironments (58) . Drug tolerance in P. aeruginosa biofilms is considered to be primarily due to a large proportion of stationary-phase-like metabolically inactive cells (44, 59) . However, such analyses are inherently complicated by the complex relationship between the bacterial physiology and components of the biofilm microenvironment, including ECM.
The role of biofilms in subverting host immunity during chronic infection is evident in the pathogenesis of P. aeruginosa and S. aureus. In P. aeruginosa, two biofilm-associated extracellular materials, alginate and rhamnolipid, have been implicated in protection against host immunity. Whereas alginate protects the bacteria from the macrophages, rhamnolipid protects by inducing necrosis of polymorphonuclear leukocytes (PMNs) (51, 60) . S. aureus biofilms appear to misguide the host response to facilitate greater persistence of microbes. In the later stages of infection, the biofilms induce Th2-dependent humoral immune responses that are less effective than the Th1-dependent stronger T-cell response induced during early stages of infection (5).
MYCOBACTERIA SPONTANEOUSLY FORM BIOFILMS
Unless detergent is added, most mycobacterial species in liquid culture display a strong propensity to attach to substrata, and to each other, to form a variety of microscopic as well as macroscopic multicellular structures (Fig. 2) . Besides such homospecies biofilms in vitro, many nontuberculous mycobacteria (NTM), including opportunistic pathogens, have been ubiquitously found as heterospecies biofilms in environmental specimens. Mycobacterium chelonae, Mycobacterium fortuitum, Mycobacterium gordonae, and Mycobacterium tarrae/ nonchromogenicum were detected in 90% of polymicrobial biofilms obtained from domestic water supplies and water treatment plants (61) . Similarly, water distribution systems including showerheads and faucets are the predominant habitat for the polymicrobial biofilms containing Mycobacterium avium, Mycobacterium intracellulare, and Mycobacterium xenopi (62) (63) (64) (65) (66) . Moreover, biofilms of NTM are highly tolerant to disinfectant chlorine and thus pose a significant public health challenge to effective control strategies for nosocomial infections (67, 68) .
The propensity of mycobacteria to form biofilms raises many fundamental questions such as (i) how the multicellular architectures are developed, (ii) what unique phenotypes are associated with mycobacterial biofilms, (iii) how such phenotypes originate, and most importantly, (iv) whether there is any relationship between biofilms and virulence as well as characteristic persistence of mycobacterial infections. The most reasonable approach to these questions involves genetic analysis of mycobacterial biofilms. Not surprisingly, novel molecular insights have been gained in the last 10 years, which also witnessed major breakthroughs in the development of mycobacterial genetic tools.
GENETICS OF MYCOBACTERIAL BIOFILMS Structural Development
In a genetic screen of transposon insertion mutants of Mycobacterium smegmatis, Recht and Kolter isolated attachment-defective mutants with disruptions in genes involved in acetylation of glycopeptidolipid (GPL) (69) . GPL was subsequently found to be also required for the development of M. avium biofilms (70, 71) . Because GPL is also a potent immunomodulator (72), the question arises whether biofilms directly influence the pathology and clinical symptoms of M. avium infections. A direct association between biofilms and virulence of M. avium is further consistent with the fact that biofilm-defective mutants of M. avium cannot colonize and translocate through bronchial epithelial cells (73) . Similar linkage between virulence and biofilms exists for another NTM, Mycobacterium ulcerans. M. ulcerans colonizes an aquatic insect, Naucoris cimicoides, primarily as matrixencapsulated multicellular structures containing large amounts of an extracellular toxin, mycolactone (74, 75) . Because mycolactone is the major virulence factor of M. ulcerans, its biofilms can be thought to directly cause the pathological features of Buruli ulcers. Evidence of a programmed development of biofilms proceeding through distinct stages emerges from the phenotype of a ΔgroEL1 mutant of M. smegmatis (76) . While the mutant seems indistinguishable from the wild type during the first 3 days (early stage) of growth, it fails to form a mature pellicle, typically seen after 5 days (late stage) of wild-type growth (76) . Furthermore, GroEL-1 directly interacts with the fatty acid synthase complex II (FAS II) to modulate mycolic acid biosynthesis during maturation of pellicles (76) . This regulated interaction appears to induce the synthesis of free mycolic acids (FM), an abundant extracellular lipid, in the later stages of biofilms (77) . Given the abundance and extracellular location of FM, as well as its association with the matured architecture of biofilms, it can be reasonably considered one of the components of the matrix. Interestingly, FM is also an abundant extracellular lipid of M. tuberculosis pellicles (78), although unlike the alphaand epoxy-FM produced by M. smegmatis, M. tuberculosis predominantly produces methoxy-FM (77, 78) (Fig. 3) . The structural distinction between the FMs of M. smegmatis and M. tuberculosis raises the possibility that the biofilms of the two species, despite being morphologically similar, could have distinct properties. Nonetheless, the abundance of FM in biofilms is of particular interest because the majority of the mycolic acids synthesized by planktonic bacteria are esterified to either mycolyl-arabinogalactan-peptidoglycan complex, trehalose, or other sugars (79) . Thus, a question arises as to whether FM is generated by cleavage of the mycolyl esters or is synthesized and secreted de novo through a dedicated FAS II complex. Discovery of a cutinase-like serine esterase in M. smegmatis, Msmeg_1529, with an ability to hydrolyze trehalose dimycolate into FM supports the former mechanism (77). However, modulation of FAS II complex by GroEL1 during FM synthesis in M. smegmatis also implies regulation in the biosynthetic pathways of mycolic acids.
In addition to FM and GPL, mycolyl diacyl glycerol (MDAG) is also implicated in biofilm formation of M. smegmatis (80) , indicating that the multicellular architecture of mycobacteria is predominantly waxy. Loss of biofilm development in M. tuberculosis by disruption of putative polyketide synthases, pks16 and pks1/15, or altered synthesis of mycolic acids through deletion in a nucleoid-associated protein, further supports the critical contribution of surface lipids in self-assemblage of mycobacteria (78, 81, 82) .
It is noteworthy that mycobacteria in detergent-free media often produce a polysaccharide-rich capsular material on the surface (83, 84) . Although a clear role of capsular structures in biofilm architectures remains undetermined, lipooligosaccharides on the M. marinum surface appear to be required for its biofilm development (85) . In summary, the structures of mycobacterial biofilms are likely assembled by various kinds of molecules, although a subset of these could be shared as core components by multiple species.
Physiological Adaptations
Genetic evidence for mycobacterial adaptation to the limiting environments of biofilms can be derived from exclusive induction of 82 genes in M. smegmatis biofilms (86) . These can be classified into various functional categories such as lipid biosynthesis, nutrient transport, toxin efflux, iron sequestration, DNA damage repair, transcriptional regulation, etc. (86) . The gene-expression pattern is further complemented by genetic analysis of mutants involved in the process. For example, the upregulation of iron sequestration machinery in M. smegmatis biofilms is consistent with the impaired biofilms of a mutant that fails to sequester iron from the environment, despite its normal growth in planktonic culture (86) . Increased iron sequestration in biofilms could possibly be due to either limited supply of the metal in the inner regions of biofilms or specialized metabolic requirement or both. Similar arguments apply to the induced expression of transporters as well as efflux pumps in M. smegmatis biofilms (86) . Although the mechanisms underlying the regulation of gene expression during mycobacterial growth in biofilms remain unclear, a mutation in rpoZ appears to affect the developmental process of M. smegmatis biofilms (87) .
The roles of environmental stimulants and intercellular interactions in development of mycobacterial biofilms remain largely unexplored, although the likelihood of such mechanisms is supported by multiple studies. Growth of M. avium biofilms is enhanced in response to the exogenous signaling molecule autoinducer-2, as well as subinhibitory concentrations of antibiotics (71, 88) . Similarly, intercellular interaction is evident from the fact that biofilms of M. smegmatis are essential for the conjugal transfer of DNA from a donor to a recipient strain (89) . Interestingly, the recipient strain is incapable of forming biofilms on its own and therefore is likely to be actively recruited in the multicellular structure by the donor strain for conjugation (89) .
PHENOTYPIC RESISTANCE OF MYCOBACTERIAL BIOFILMS
Mycobacterial biofilms in vitro display greater phenotypic resistance to antibiotics than planktonic cultures (78, 90, 91) . Although the mechanisms of drug tolerance remain unclear, both extrinsic factors such as ECM and intrinsic physiology of the bacteria are likely to contribute to the phenomenon. While the waxy ECM can restrict the exposure to antibiotics, limiting growth conditions in biofilm microenvironments could lead to a drug-refractory physiology of the constituent bacteria. This scenario is further supported by the fact that depleted nutrients and oxygen promote the development of nonreplicating but viable drug-tolerant persisters of mycobacteria (92, 93) . Recently, phenotypic drug tolerance in mycobacteria has also been linked to heterogeneity in cell length, as a result of asymmetric cell division, and cell-to-cell stochastic fluctuation in gene expression (94, 95) . Drug tolerance through these mechanisms can also be envisaged to occur in mycobacterial biofilms because of the asynchronous growth of the cells in nonuniform microenvironments.
Importantly, impaired biofilms of genetically unrelated mutants of M. tuberculosis as well as M. smegmatis are relatively more sensitive to antibiotics than their corresponding parent wild type, implying that maturation of structural assembly appears to be critical for the phenotypic tolerance (Fig. 4) . This provides a strong incentive for discovery of chemical inhibitors of mycobacterial biofilms. Such inhibitors in conjunction with conventional drugs can potentially facilitate effective and shorter treatment of mycobacterial infections.
RELEVANCE OF BIOFILM FORMATION TO TUBERCULOSIS
In a 7-year-long histopathological study of lung lesions from hundreds of active tuberculosis (TB) cases, Georges Canetti documented numerous micrographs with biofilm-like multicellular aggregates of M. tuberculosis (96) . Given that M. tuberculosis has a natural tendency to form drug-tolerant biofilms in vitro, the in vivo aggregates certainly open up important questions about the conditions in which these are formed and their possible involvement in long-term persistence of the pathogen against host defense mechanisms and antibiotics.
In vivo persistence of M. tuberculosis against antibiotics is manifested by a prolonged and complicated treatment regimen of TB involving multiple antibiotics administered daily for at least 6 to 9 months (97). It is clinically demonstrated that the prolonged regimen is necessary for clearing a small number (<5%) of phenotypically resistant bacilli, while the majority are cleared within days of treatment (98) . Interestingly, similar biphasic clearance patterns are observed when biofilms are exposed to antibiotics (78) . Although where and how these rare persisters survive in TB patients remains unknown, using the guinea pig model, Orme and colleagues found that the persisters were predominantly located in multicellular microcolonies located in the acellular rim of granulomas (99) . Further extension of this observation with multiple biofilm-defective mutants of M. tuberculosis, such as pks16, helY, pks1/15, etc. (78, 81) , is likely to strengthen the possible association between in vivo persistence and the multicellular growth of the pathogens.
Besides persistence against antibiotics, biofilms could also be envisioned as a key persistence strategy of M. tuberculosis against the host immune system in chronic infections, particularly those without any clinical symptoms. Asymptomatic infections are prevalent in more than 90% of an estimated two billion people infected with M. tuberculosis worldwide (97). Long-term asymptomatic persistence of M. tuberculosis, clinically defined as latent TB (LTB), has long been associated with a metabolically dormant pathogen "hidden" from the host immune system (100). However, this view is contradicted by recent studies in which LTB is associated with (i) active engagement of immune cells (101) , (ii) the presence of drug-responsive lesions (102, 103) , (iii) active replication of bacilli (104) , and (iv) a pathology that overlaps with active disease in terms of heterogeneity in lesion distribution, size, and morphology (105) . Together, these findings suggest that at least a subset of LTB might represent a dynamic host-pathogen interaction that maintains host inflammation below a symptomatic threshold despite active growth of M. tuberculosis. A possible path to such a scenario could involve immune subversion by actively replicating M. tuberculosis in biofilms, coated with lipids that fail to elicit any inflammatory response in the host. This idea gains support from the fact that unlike many other surface lipids of M. tuberculosis, purified FM fails to induce a proinflammatory response in macrophages (Y. Yang and A. K. Ojha, unpublished result). Novel mutants with specific defects in biofilm-associated extracellular lipids including FM could be invaluable in testing this hypothesis.
CONCLUSION
An increasing body of evidence suggests that biofilms are not only the spontaneous manifestations of mycobacterial growth, but also promote their persistence against exogenous threats. However, a significant knowledge gap exists in the molecular mechanisms underlying structural as well as phenotypic developments of mycobacterial biofilms. With new high-throughput genetic and biochemical tools as well as advanced microscopic techniques, there is an enormous opportunity to explore the biological complexities and intercellular dynamics of multicellular structures and their likely involvement in the extraordinary recalcitrance of mycobacterial infections. 
